Cancer Genetics, Keck Researcher Team on Lymphoma Markers | GenomeWeb

NEW YORK (GenomeWeb) – Cancer Genetics today said that it will collaborate with a researcher at Keck Medicine of the University of Southern California to identify genomic markers of diffuse large B-cell lymphoma.

The Rutherford, NJ-based firm said that it will work with Keck pathologist Imran Siddiqi to identify and evaluate prognostic markers for the disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.